December 25, 2018
The Japan arm of Mundipharma said on December 21 that it has filed a new drug application (NDA) in Japan for its anesthetic agent remimazolam for the induction and maintenance of general anesthesia. Remimazolam, licensed from Germany’s Paion in December...read more